Vital Farms Faces Class Action Lawsuit Over Alleged Securities Fraud
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Should l Buy VITL?
Source: Globenewswire
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Vital Farms, alleging securities fraud by the company and certain officers, with investors needing to apply by May 26, 2026, to be appointed as Lead Plaintiff, indicating significant legal risks that could tarnish the company's reputation.
- Earnings Miss: In its annual report released on February 26, 2026, Vital Farms reported annual revenue of $759.44 million, falling short of its prior guidance of $775 million, and earnings per share of $0.35, below the consensus estimate of $0.39, reflecting a decline in performance that may erode investor confidence.
- ERP System Disruptions: The company disclosed that its implementation of an enterprise resource planning (ERP) system caused “temporary disruptions in order and fulfillment levels,” with the CFO noting that volume growth is lagging expectations, highlighting challenges in the company's technological transition that could impact future operational efficiency.
- Stock Price Decline: Following the disappointing earnings report and ERP implementation issues, Vital Farms' stock price fell by $2.68, or 10.81%, closing at $22.11 on February 26, 2026, reflecting market concerns about the company's future performance and potential impacts on its financing capabilities.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VITL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VITL
Wall Street analysts forecast VITL stock price to rise
12 Analyst Rating
11 Buy
0 Hold
1 Sell
Strong Buy
Current: 8.940
Low
44.00
Averages
48.90
High
60.00
Current: 8.940
Low
44.00
Averages
48.90
High
60.00
About VITL
Vital Farms, Inc. offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 575 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. The Company packages, markets and distributes shell eggs, butter, and other products. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 23,500 stores nationwide. The retail varieties of its shell eggs are based on supplemental feed type, egg size, and pack size. Its egg packaging consists primarily of corrugated boxes and egg cartons. The Company offers unsalted and sea-salted varieties of its butter, which are sold in two-stick and four-stick packs. The Company’s products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Vital Farms Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in its new ERP system rollout, failing to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its successful track record and expertise in the field.
- Investor Advisory: Investors are advised to choose their legal counsel wisely, as many firms issuing notices lack actual litigation experience; Rosen Law Firm emphasizes selecting counsel with a proven track record to ensure effective protection of their rights.
See More
Vital Farms Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their representation in the class action lawsuit.
- Potential Compensation Opportunity: Investors participating in the class action may be entitled to compensation without any upfront costs, indicating a risk-free avenue for affected investors to seek recovery, thereby enhancing investor confidence in the process.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system and failed to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and resource advantages in handling such cases.
See More
Vital Farms Q1 2026 Earnings Call Insights
- Underperformance in Q1: Vital Farms reported net revenue of $187.2 million for Q1 2026, a 15.4% year-over-year increase, yet the results fell short of expectations due to unsustainable price gaps, prompting management to emphasize the need for rapid adaptation to control costs.
- Adjusted EBITDA Guidance: The company has lowered its adjusted EBITDA guidance for 2026 to a range of $0 to $10 million, anticipating a negative impact of $32 million from supply management costs, indicating increased cash flow pressures.
- Strategic Contraction: Vital Farms has decided to exit its butter business and pause construction on the Vital Crossroads facility in Indiana, reducing capital expenditure guidance to $70 million to $75 million, reflecting a cautious approach to future investments.
- Market Outlook: Management expects revenue-generating volume growth to turn positive in Q3 and anticipates growth acceleration in Q4, despite current pricing pressures and oversupply challenges, aiming to restore gross margins to 30% by 2027.
See More
Midday Stock Movements of Major Companies
- Planet Fitness Earnings Downgrade: Planet Fitness shares fell nearly 33% after the gym operator lowered its full-year earnings outlook, now projecting only a 4% year-over-year growth, down from a previous forecast of 9%-10%, which negatively impacts market confidence.
- Vital Farms Surprise Loss: Vital Farms, the egg producer, dropped 20% following a surprise loss of 3 cents per share in Q1, against analyst expectations of a 6-cent profit, and the company also cut its full-year earnings outlook, indicating increasing industry pressures.
- Datadog Exceeds Expectations: Datadog shares surged 28% after reporting Q1 earnings of 61 cents per share, surpassing the 51-cent consensus, with Q2 revenue guidance between $1.07 billion and $1.08 billion, reflecting strong market demand.
- AAON Revenue Surge: AAON, the air conditioning and heating equipment manufacturer, saw its shares soar 40% after Q1 earnings, EBITDA, and revenue all exceeded Wall Street estimates, raising its full-year revenue guidance by as much as 45%, showcasing robust growth potential.
See More
Vital Farms Reports Increased Losses in Q1
- Financial Performance Decline: Vital Farms reported a net loss of $1.52 million in Q1, a stark contrast to a profit of $16.90 million in the previous year, indicating a significant deterioration in profitability that could undermine investor confidence.
- Earnings Per Share Drop: The company posted a loss per share of $0.03 compared to earnings of $0.37 last year, reflecting major challenges in profitability that may lead to further declines in stock price.
- Adjusted EBITDA Outlook Downgrade: Adjusted EBITDA fell from $27.48 million last year to $5.02 million, with the fiscal 2026 EBITDA forecast slashed from $105 million to a range of $0 to $10 million, highlighting uncertainty in future profitability.
- Weak Revenue Growth: Although revenue increased from $162.19 million to $187.16 million, the company lowered its fiscal 2026 net revenue guidance to $775 million to $800 million, significantly below the previous forecast of $900 million to $920 million, suggesting potential weakening in market demand.
See More
Vital Farms Faces Class Action Lawsuit
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against Vital Farms (VITL) in the U.S. District Court for the Western District of Texas on behalf of investors who purchased securities between May 8, 2025, and February 26, 2026, indicating significant legal risks for the company.
- False Statement Allegations: The complaint alleges that Vital Farms misled investors by claiming that the risks associated with its new enterprise resource planning (ERP) system were merely hypothetical, while actual delays resulted in the company missing consensus earnings per share, leading to investor losses.
- Investor Rights Protection: Investors must apply by May 26, 2026, to be appointed as lead plaintiffs in the lawsuit, highlighting the potential impact of this case on investor rights and interests.
- Law Firm Background: Bragar Eagel & Squire is a nationally recognized law firm specializing in securities, derivative, and commercial litigation, underscoring its expertise and commitment to investor protection.
See More
Vital Farms Securities Class Action Notice
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their right to compensation.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in its new ERP system rollout, failing to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Credentials: Rosen Law Firm specializes in securities class actions and has recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its successful track record and expertise in the field.
- Investor Advisory: Investors are advised to choose their legal counsel wisely, as many firms issuing notices lack actual litigation experience; Rosen Law Firm emphasizes selecting counsel with a proven track record to ensure effective protection of their rights.
See More
Vital Farms Securities Class Action Reminder
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their representation in the class action lawsuit.
- Potential Compensation Opportunity: Investors participating in the class action may be entitled to compensation without any upfront costs, indicating a risk-free avenue for affected investors to seek recovery, thereby enhancing investor confidence in the process.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system and failed to disclose the impact of these delays on its 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm's Advantage: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, showcasing its expertise and resource advantages in handling such cases.
See More
Vital Farms Q1 2026 Earnings Call Insights
- Underperformance in Q1: Vital Farms reported net revenue of $187.2 million for Q1 2026, a 15.4% year-over-year increase, yet the results fell short of expectations due to unsustainable price gaps, prompting management to emphasize the need for rapid adaptation to control costs.
- Adjusted EBITDA Guidance: The company has lowered its adjusted EBITDA guidance for 2026 to a range of $0 to $10 million, anticipating a negative impact of $32 million from supply management costs, indicating increased cash flow pressures.
- Strategic Contraction: Vital Farms has decided to exit its butter business and pause construction on the Vital Crossroads facility in Indiana, reducing capital expenditure guidance to $70 million to $75 million, reflecting a cautious approach to future investments.
- Market Outlook: Management expects revenue-generating volume growth to turn positive in Q3 and anticipates growth acceleration in Q4, despite current pricing pressures and oversupply challenges, aiming to restore gross margins to 30% by 2027.
See More
Midday Stock Movements of Major Companies
- Planet Fitness Earnings Downgrade: Planet Fitness shares fell nearly 33% after the gym operator lowered its full-year earnings outlook, now projecting only a 4% year-over-year growth, down from a previous forecast of 9%-10%, which negatively impacts market confidence.
- Vital Farms Surprise Loss: Vital Farms, the egg producer, dropped 20% following a surprise loss of 3 cents per share in Q1, against analyst expectations of a 6-cent profit, and the company also cut its full-year earnings outlook, indicating increasing industry pressures.
- Datadog Exceeds Expectations: Datadog shares surged 28% after reporting Q1 earnings of 61 cents per share, surpassing the 51-cent consensus, with Q2 revenue guidance between $1.07 billion and $1.08 billion, reflecting strong market demand.
- AAON Revenue Surge: AAON, the air conditioning and heating equipment manufacturer, saw its shares soar 40% after Q1 earnings, EBITDA, and revenue all exceeded Wall Street estimates, raising its full-year revenue guidance by as much as 45%, showcasing robust growth potential.
See More
Vital Farms Reports Increased Losses in Q1
- Financial Performance Decline: Vital Farms reported a net loss of $1.52 million in Q1, a stark contrast to a profit of $16.90 million in the previous year, indicating a significant deterioration in profitability that could undermine investor confidence.
- Earnings Per Share Drop: The company posted a loss per share of $0.03 compared to earnings of $0.37 last year, reflecting major challenges in profitability that may lead to further declines in stock price.
- Adjusted EBITDA Outlook Downgrade: Adjusted EBITDA fell from $27.48 million last year to $5.02 million, with the fiscal 2026 EBITDA forecast slashed from $105 million to a range of $0 to $10 million, highlighting uncertainty in future profitability.
- Weak Revenue Growth: Although revenue increased from $162.19 million to $187.16 million, the company lowered its fiscal 2026 net revenue guidance to $775 million to $800 million, significantly below the previous forecast of $900 million to $920 million, suggesting potential weakening in market demand.
See More
Vital Farms Faces Class Action Lawsuit
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against Vital Farms (VITL) in the U.S. District Court for the Western District of Texas on behalf of investors who purchased securities between May 8, 2025, and February 26, 2026, indicating significant legal risks for the company.
- False Statement Allegations: The complaint alleges that Vital Farms misled investors by claiming that the risks associated with its new enterprise resource planning (ERP) system were merely hypothetical, while actual delays resulted in the company missing consensus earnings per share, leading to investor losses.
- Investor Rights Protection: Investors must apply by May 26, 2026, to be appointed as lead plaintiffs in the lawsuit, highlighting the potential impact of this case on investor rights and interests.
- Law Firm Background: Bragar Eagel & Squire is a nationally recognized law firm specializing in securities, derivative, and commercial litigation, underscoring its expertise and commitment to investor protection.
See More
